AstraZeneca: AstraZeneca's oral breast cancer drug Truqap greenlit for NHS use
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
Read full article »
CEO
Pascal Soriot
AstraZeneca is an England-based biopharmaceutical company that researches and develops prescription medicines for the treatment of cancer and renal diseases.
Read more